Business & Industry
- Pfizer files lawsuit against Metsera and its directors and Novo Nordisk for breach of merger agreement
- Pfizer receives early clearance from U.S. Federal Trade Commission for Metsera acquisition
- Pfizer addresses proposal for Metsera
- Bayer's Lynkuet™ (elinzanetant) approved in the U.S. for treatment of moderate to severe vasomotor symptoms due to menopause
- Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)
Research & Development
- Machine learning drives drug repurposing for neuroblastoma
- New technique lights up where drugs go in the body, cell by cell
- Right blood pressure drug can reduce healthcare costs
- The natural human protein drug may halt neuron death in Alzheimer's disease
- Groundbreaking discovery turns household plastic recycling into anti-cancer medication
- Accelerated cancer drug approvals deliver limited survival gains at high cost
- Tiny viral switch offers hope against drug-resistant bacteria
Conferences & Events
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
- CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
- CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
- FDA expands artificial intelligence capabilities with agentic AI deployment
- FDA approves first gene therapy for treatment of aromatic L-amino acid decarboxylase deficiency
- FDA approves new treatment for hemophilia A or B
- FDA approves nasal spray influenza vaccine for self- or caregiver-administration
- FDA approves first nasal spray for treatment of anaphylaxis